Thermo Fisher Scientific Proceeds from disposition of marketable securities and other investments increased by 12400.0% to $250.00M in Q1 2026 compared to the prior quarter.
High proceeds indicate the conversion of financial assets into cash, often to fund operations or acquisitions.
Cash inflows generated from the sale, maturity, or collection of financial investments and marketable securities. This r...
Standard for companies managing large investment portfolios.
other_proceeds_from_sale_maturity_and_collections_of_inv_6d369e| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.00M | $250.00M |
| QoQ Change | — | >999% |
| YoY Change | — | >999% |